Submit Deal

ARIX BIOSCIENCE

Summary

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.

Deals Overview

Total Deals5

Valued Deals4

Total Value£ 2.52 B

Avg. Deal Size£ 630 M

Market Context

Senior Management

Joe Anderson
CEO
Naseem Amin
Chairman
Peregrine Moncreiffe
Chairman

Sort

powerscourt

pr advisors (2)

2 Shared Deals

1 For | 1 Opposite

£ 185 M

Total Value

optimum strategic communications

pr advisors (1)

1 Shared Deal

1 For

£ 2.12 B

Total Value

gibson dunn & crutcher

HQ - Los Angeles

legal advisors (1)

1 Shared Deal

1 Opposite

£ 2.12 B

Total Value

jp morgan

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 2.12 B

Total Value

cravath swaine & moore

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 Opposite

£ 2.12 B

Total Value

gasthalter & co

HQ - New York

pr advisors (2)

2 Shared Deals

1 Along | 1 Opposite

£ 2.30 B

Total Value

kkh advisors

pr advisors (1)

1 Shared Deal

1 Along

£ 2.12 B

Total Value

cooley

HQ - Palo Alto

legal advisors (2)

2 Shared Deals

1 Along | 1 Opposite

£ 2.22 B

Total Value

centerview partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 Along

£ 2.12 B

Total Value

lifesci partners

HQ - New York

pr advisors (1)

1 Shared Deal

1 Opposite

£ 110 M

Total Value

1ab

pr advisors (1)

1 Shared Deal

1 Opposite

£ 108 M

Total Value

jefferies & company

HQ - New York

financial advisors (1)

brokers (1)

2 Shared Deals

2 For

£ 370 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy